The updated guideline has 16 statements covering areas including risk stratification, red blood cell transfusion and pre-endoscopic medical therapy.
Some of the ACG’s recommendations include:
- Using an infusion of erythromycin before endoscopy in patients with upper gastrointestinal bleeding
- Performing an endoscopy on patients admitted to or under observation for upper gastrointestinal bleeding within 24 hours of presentation
- Taking a restrictive policy of red blood cell transfusion for patients with upper gastrointestinal bleeding
- Giving endoscopic therapy in patients with upper gastrointestinal bleeding due to ulcers with active bleeding
- Patients with bleeding ulcers who failed endoscopic therapy be treated with transcatheter arterial embolization
Read the full guideline here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.